Inflammatory monocytes mediate control of acute alphavirus infection in mice

PLoS Pathogens

Volumn 13, Issue 12, 2017, Pages

  Haist, Kelsey C ^a   Burrack, Kristina S ^a,b   Davenport, Bennett J ^a   Morrison, Thomas E ^a  

^a UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; DIPHTHERIA TOXIN; INTERFERON; INTERFERON REGULATORY FACTOR 7; VIRUS RNA; CCR2 PROTEIN, MOUSE; CHEMOKINE RECEPTOR CCR2; HEPARIN BINDING EPIDERMAL GROWTH FACTOR; INTERFERON REGULATORY FACTOR 3; IPS-1 PROTEIN, MOUSE; IRF3 PROTEIN, MOUSE; IRF7 PROTEIN, MOUSE; LY ANTIGEN; LY-6C ANTIGEN, MOUSE; SIGNAL TRANSDUCING ADAPTOR PROTEIN;

ADAPTIVE IMMUNITY; ADOPTIVE TRANSFER; ALPHAVIRUS INFECTION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIVIRAL ACTIVITY; ARTICLE; CELL ISOLATION; CELL POPULATION; CHIKUNGUNYA; CHIKUNGUNYA VIRUS; CHIMERA; CONTROLLED STUDY; DISEASE SEVERITY; FLOW CYTOMETRY; GENE EXPRESSION; GENE OVEREXPRESSION; HEMATOPOIETIC CELL; INFLAMMATORY CELL; MACROPHAGE; MONOCYTE; MOUSE; MUSCULOSKELETAL DISEASE; NATURAL KILLER CELL; NONHUMAN; PATHOGENESIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; ROSS RIVER VIRUS; VIRAL PLAQUE ASSAY; VIRUS LOAD; VIRUS MUTANT; VIRUS STRAIN; ANIMAL; BIOSYNTHESIS; C57BL MOUSE; DEFICIENCY; DRUG EFFECT; GENETICS; HUMAN; IMMUNOLOGY; INFLAMMATION; KNOCKOUT MOUSE; METABOLISM; PATHOGENICITY; TRANSGENIC MOUSE; VIROLOGY; VIRULENCE;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ALPHAVIRUS INFECTIONS; ANIMALS; ANTIGENS, LY; CHIKUNGUNYA VIRUS; DIPHTHERIA TOXIN; HEPARIN-BINDING EGF-LIKE GROWTH FACTOR; HUMANS; INFLAMMATION; INTERFERON REGULATORY FACTOR-3; INTERFERON REGULATORY FACTOR-7; INTERFERON TYPE I; KILLER CELLS, NATURAL; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICE, TRANSGENIC; MONOCYTES; RECEPTORS, CCR2; ROSS RIVER VIRUS; VIRAL LOAD; VIRULENCE;

EID: 85039916468     PISSN: 15537366     EISSN: 15537374     Source Type: Journal    
DOI: 10.1371/journal.ppat.1006748     Document Type: Article

References (80)

1. Suhrbier A, Jaffar-Bandjee MC, Gasque P, Arthritogenic alphaviruses—an overview. Nat Rev Rheumatol. 2012;8(7):420–9. Epub 2012/05/09. doi: 10.1038/nrrheum.2012.64 22565316.
2. Weaver SC, Lecuit M, Chikungunya virus and the global spread of a mosquito-borne disease. N Engl J Med. 2015;372(13):1231–9. doi: 10.1056/NEJMra1406035 25806915.
3. Leparc-Goffart I, Nougairede A, Cassadou S, Prat C, de Lamballerie X, Chikungunya in the Americas. Lancet. 2014;383(9916):514. Epub 2014/02/11. doi: 10.1016/S0140-6736(14)60185-9 24506907.
4. Petersen LR, Powers AM, Chikungunya: epidemiology. F1000Res. 2016;5. doi: 10.12688/f1000research.7171.1 26918158.
5. Morrison TE, Reemergence of chikungunya virus. J Virol. 2014;88(20):11644–7. doi: 10.1128/JVI.01432-14 25078691.
6. Claflin SB, Webb CE, Ross River Virus: Many Vectors and Unusual Hosts Make for an Unpredictable Pathogen. PLoS Pathog. 2015;11(9):e1005070. doi: 10.1371/journal.ppat.1005070 26335937.
7. Mylonas AD, Brown AM, Carthew TL, McGrath B, Purdie DM, Pandeya N, et al. Natural history of Ross River virus-induced epidemic polyarthritis. Med J Aust. 2002;177(7):356–60. 12358577.
8. Soden M, Vasudevan H, Roberts B, Coelen R, Hamlin G, Vasudevan S, et al. Detection of viral ribonucleic acid and histologic analysis of inflamed synovium in Ross River virus infection. Arthritis Rheum. 2000;43(2):365–9. doi: 10.1002/1529-0131(200002)43:2<365::AID-ANR16>3.0.CO;2-E 10693876.
9. Harley D, Bossingham D, Purdie DM, Pandeya N, Sleigh AC, Ross River virus disease in tropical Queensland: evolution of rheumatic manifestations in an inception cohort followed for six months. Med J Aust. 2002;177(7):352–5. 12358576.
10. Borgherini G, Poubeau P, Jossaume A, Gouix A, Cotte L, Michault A, et al. Persistent arthralgia associated with chikungunya virus: a study of 88 adult patients on reunion island. Clin Infect Dis. 2008;47(4):469–75. doi: 10.1086/590003 18611153.
11. Sissoko D, Malvy D, Ezzedine K, Renault P, Moscetti F, Ledrans M, et al. Post-epidemic Chikungunya disease on Reunion Island: course of rheumatic manifestations and associated factors over a 15-month period. PLoS Negl Trop Dis. 2009;3(3):e389. doi: 10.1371/journal.pntd.0000389 19274071.
12. Gerardin P, Fianu A, Michault A, Mussard C, Boussaid K, Rollot O, et al. Predictors of Chikungunya rheumatism: a prognostic survey ancillary to the TELECHIK cohort study. Arthritis Res Ther. 2013;15(1):R9. doi: 10.1186/ar4137 23302155.
13. Schilte C, Staikowsky F, Couderc T, Madec Y, Carpentier F, Kassab S, et al. Chikungunya virus-associated long-term arthralgia: a 36-month prospective longitudinal study. PLoS Negl Trop Dis. 2013;7(3):e2137. doi: 10.1371/journal.pntd.0002137 23556021.
14. Poo YS, Nakaya H, Gardner J, Larcher T, Schroder WA, Le TT, et al. CCR2 deficiency promotes exacerbated chronic erosive neutrophil-dominated chikungunya virus arthritis. J Virol. 2014;88(12):6862–72. doi: 10.1128/JVI.03364-13 24696480.
15. Chen W, Foo SS, Rulli NE, Taylor A, Sheng KC, Herrero LJ, et al. Arthritogenic alphaviral infection perturbs osteoblast function and triggers pathologic bone loss. Proc Natl Acad Sci U S A. 2014;111(16):6040–5. doi: 10.1073/pnas.1318859111 24733914.
16. Herrero LJ, Sheng KC, Jian P, Taylor A, Her Z, Herring BL, et al. Macrophage migration inhibitory factor receptor CD74 mediates alphavirus-induced arthritis and myositis in murine models of alphavirus infection. Arthritis Rheum. 2013;65(10):2724–36. doi: 10.1002/art.38090 23896945.
17. Gunn BM, Morrison TE, Whitmore AC, Blevins LK, Hueston L, Fraser RJ, et al. Mannose binding lectin is required for alphavirus-induced arthritis/myositis. PLoS Pathog. 2012;8(3):e1002586. doi: 10.1371/journal.ppat.1002586 22457620.
18. Herrero LJ, Nelson M, Srikiatkhachorn A, Gu R, Anantapreecha S, Fingerle-Rowson G, et al. Critical role for macrophage migration inhibitory factor (MIF) in Ross River virus-induced arthritis and myositis. Proc Natl Acad Sci U S A. 2011;108(29):12048–53. doi: 10.1073/pnas.1101089108 21730129.
19. Lidbury BA, Rulli NE, Suhrbier A, Smith PN, McColl SR, Cunningham AL, et al. Macrophage-derived proinflammatory factors contribute to the development of arthritis and myositis after infection with an arthrogenic alphavirus. J Infect Dis. 2008;197(11):1585–93. doi: 10.1086/587841 18433328.
20. Morrison TE, Fraser RJ, Smith PN, Mahalingam S, Heise MT, Complement contributes to inflammatory tissue destruction in a mouse model of Ross River virus-induced disease. J Virol. 2007;81(10):5132–43. doi: 10.1128/JVI.02799-06 17314163.
21. Teo TH, Her Z, Tan JJ, Lum FM, Lee WW, Chan YH, et al. Caribbean and La Reunion Chikungunya Virus Isolates Differ in Their Capacity To Induce Proinflammatory Th1 and NK Cell Responses and Acute Joint Pathology. J Virol. 2015;89(15):7955–69. doi: 10.1128/JVI.00909-15 25995257.
22. Teo TH, Lum FM, Claser C, Lulla V, Lulla A, Merits A, et al. A pathogenic role for CD4+ T cells during Chikungunya virus infection in mice. J Immunol. 2013;190(1):259–69. doi: 10.4049/jimmunol.1202177 23209328.
23. Long KM, Whitmore AC, Ferris MT, Sempowski GD, McGee C, Trollinger B, et al. Dendritic cell immunoreceptor regulates Chikungunya virus pathogenesis in mice. J Virol. 2013;87(10):5697–706. doi: 10.1128/JVI.01611-12 23487448.
24. Morrison TE, Simmons JD, Heise MT, Complement receptor 3 promotes severe ross river virus-induced disease. J Virol. 2008;82(22):11263–72. doi: 10.1128/JVI.01352-08 18787004.
25. Gardner J, Anraku I, Le TT, Larcher T, Major L, Roques P, et al. Chikungunya virus arthritis in adult wild-type mice. J Virol. 2010;84(16):8021–32. doi: 10.1128/JVI.02603-09 20519386.
26. Morrison TE, Oko L, Montgomery SA, Whitmore AC, Lotstein AR, Gunn BM, et al. A mouse model of chikungunya virus-induced musculoskeletal inflammatory disease: evidence of arthritis, tenosynovitis, myositis, and persistence. Am J Pathol. 2011;178(1):32–40. doi: 10.1016/j.ajpath.2010.11.018 21224040.
27. Lidbury BA, Simeonovic C, Maxwell GE, Marshall ID, Hapel AJ, Macrophage-induced muscle pathology results in morbidity and mortality for Ross River virus-infected mice. J Infect Dis. 2000;181(1):27–34. doi: 10.1086/315164 10608747.
28. Morrison TE, Whitmore AC, Shabman RS, Lidbury BA, Mahalingam S, Heise MT, Characterization of Ross River virus tropism and virus-induced inflammation in a mouse model of viral arthritis and myositis. J Virol. 2006;80(2):737–49. doi: 10.1128/JVI.80.2.737-749.2006 16378976.
29. Ozden S, Huerre M, Riviere JP, Coffey LL, Afonso PV, Mouly V, et al. Human muscle satellite cells as targets of Chikungunya virus infection. PLoS One. 2007;2(6):e527. doi: 10.1371/journal.pone.0000527 17565380.
30. Hoarau JJ, Jaffar Bandjee MC, Krejbich Trotot P, Das T, Li-Pat-Yuen G, Dassa B, et al. Persistent chronic inflammation and infection by Chikungunya arthritogenic alphavirus in spite of a robust host immune response. J Immunol. 2010;184(10):5914–27. doi: 10.4049/jimmunol.0900255 20404278.
31. Fraser JR, Cunningham AL, Clarris BJ, Aaskov JG, Leach R, Cytology of synovial effusions in epidemic polyarthritis. Aust N Z J Med. 1981;11(2):168–73. 6944041.
32. Hazelton RA, Hughes C, Aaskov JG, The inflammatory response in the synovium of a patient with Ross River arbovirus infection. Aust N Z J Med. 1985;15(3):336–9. 2998316.
33. Taylor A, Sheng KC, Herrero LJ, Chen W, Rulli NE, Mahalingam S, Methotrexate treatment causes early onset of disease in a mouse model of Ross River virus-induced inflammatory disease through increased monocyte production. PLoS One. 2013;8(8):e71146. doi: 10.1371/journal.pone.0071146 23951095.
34. Tsou CL, Peters W, Si Y, Slaymaker S, Aslanian AM, Weisberg SP, et al. Critical roles for CCR2 and MCP-3 in monocyte mobilization from bone marrow and recruitment to inflammatory sites. J Clin Invest. 2007;117(4):902–9. doi: 10.1172/JCI29919 17364026.
35. Serbina NV, Pamer EG, Monocyte emigration from bone marrow during bacterial infection requires signals mediated by chemokine receptor CCR2. Nat Immunol. 2006;7(3):311–7. doi: 10.1038/ni1309 16462739.
36. Serbina NV, Salazar-Mather TP, Biron CA, Kuziel WA, Pamer EG, TNF/iNOS-producing dendritic cells mediate innate immune defense against bacterial infection. Immunity. 2003;19(1):59–70. 12871639.
37. Tacke F, Alvarez D, Kaplan TJ, Jakubzick C, Spanbroek R, Llodra J, et al. Monocyte subsets differentially employ CCR2, CCR5, and CX3CR1 to accumulate within atherosclerotic plaques. J Clin Invest. 2007;117(1):185–94. doi: 10.1172/JCI28549 17200718.
38. Palframan RT, Jung S, Cheng G, Weninger W, Luo Y, Dorf M, et al. Inflammatory chemokine transport and presentation in HEV: a remote control mechanism for monocyte recruitment to lymph nodes in inflamed tissues. J Exp Med. 2001;194(9):1361–73. 11696600.
39. Wauquier N, Becquart P, Nkoghe D, Padilla C, Ndjoyi-Mbiguino A, Leroy EM, The acute phase of Chikungunya virus infection in humans is associated with strong innate immunity and T CD8 cell activation. J Infect Dis. 2011;204(1):115–23. doi: 10.1093/infdis/jiq006 21628665.
40. Kelvin AA, Banner D, Silvi G, Moro ML, Spataro N, Gaibani P, et al. Inflammatory cytokine expression is associated with chikungunya virus resolution and symptom severity. PLoS Negl Trop Dis. 2011;5(8):e1279. doi: 10.1371/journal.pntd.0001279 21858242.
41. Chirathaworn C, Poovorawan Y, Lertmaharit S, Wuttirattanakowit N, Cytokine levels in patients with chikungunya virus infection. Asian Pac J Trop Med. 2013;6(8):631–4. doi: 10.1016/S1995-7645(13)60108-X 23790334.
42. Lohachanakul J, Phuklia W, Thannagith M, Thonsakulprasert T, Ubol S, High concentrations of circulating interleukin-6 and monocyte chemotactic protein-1 with low concentrations of interleukin-8 were associated with severe chikungunya fever during the 2009–2010 outbreak in Thailand. Microbiol Immunol. 2012;56(2):134–8. doi: 10.1111/j.1348-0421.2011.00417.x 22188545.
43. Reddy V, Mani RS, Desai A, Ravi V, Correlation of plasma viral loads and presence of Chikungunya IgM antibodies with cytokine/chemokine levels during acute Chikungunya virus infection. J Med Virol. 2014;86(8):1393–401. doi: 10.1002/jmv.23875 24523146.
44. Venugopalan A, Ghorpade RP, Chopra A, Cytokines in acute chikungunya. PLoS One. 2014;9(10):e111305. doi: 10.1371/journal.pone.0111305 25343623.
45. Teng TS, Kam YW, Lee B, Hapuarachchi HC, Wimal A, Ng LC, et al. A Systematic Meta-analysis of Immune Signatures in Patients With Acute Chikungunya Virus Infection. J Infect Dis. 2015;211(12):1925–35. doi: 10.1093/infdis/jiv049 25635123.
46. Rulli NE, Rolph MS, Srikiatkhachorn A, Anantapreecha S, Guglielmotti A, Mahalingam S, Protection from arthritis and myositis in a mouse model of acute chikungunya virus disease by bindarit, an inhibitor of monocyte chemotactic protein-1 synthesis. J Infect Dis. 2011;204(7):1026–30. doi: 10.1093/infdis/jir470 21881117.
47. Rulli NE, Guglielmotti A, Mangano G, Rolph MS, Apicella C, Zaid A, et al. Amelioration of alphavirus-induced arthritis and myositis in a mouse model by treatment with bindarit, an inhibitor of monocyte chemotactic proteins. Arthritis Rheum. 2009;60(8):2513–23. doi: 10.1002/art.24682 19644852.
48. Chen W, Foo SS, Taylor A, Lulla A, Merits A, Hueston L, et al. Bindarit, an inhibitor of monocyte chemotactic protein synthesis, protects against bone loss induced by chikungunya virus infection. J Virol. 2015;89(1):581–93. doi: 10.1128/JVI.02034-14 25339772.
49. Schilte C, Couderc T, Chretien F, Sourisseau M, Gangneux N, Guivel-Benhassine F, et al. Type I IFN controls chikungunya virus via its action on nonhematopoietic cells. J Exp Med. 2010;207(2):429–42. Epub 2010/02/04. doi: 10.1084/jem.20090851 20123960.
50. Gardner CL, Burke CW, Higgs ST, Klimstra WB, Ryman KD, Interferon-alpha/beta deficiency greatly exacerbates arthritogenic disease in mice infected with wild-type chikungunya virus but not with the cell culture-adapted live-attenuated 181/25 vaccine candidate. Virology. 2012;425(2):103–12. Epub 2012/02/07. doi: 10.1016/j.virol.2011.12.020 22305131.
51. Schilte C, Buckwalter MR, Laird ME, Diamond MS, Schwartz O, Albert ML, Cutting edge: independent roles for IRF-3 and IRF-7 in hematopoietic and nonhematopoietic cells during host response to Chikungunya infection. J Immunol. 2012;188(7):2967–71. Epub 2012/03/01. doi: 10.4049/jimmunol.1103185 22371392.
52. Rudd PA, Wilson J, Gardner J, Larcher T, Babarit C, Le TT, et al. Interferon response factors 3 and 7 protect against Chikungunya virus hemorrhagic fever and shock. J Virol. 2012;86(18):9888–98. doi: 10.1128/JVI.00956-12 22761364.
53. Couderc T, Chretien F, Schilte C, Disson O, Brigitte M, Guivel-Benhassine F, et al. A mouse model for Chikungunya: young age and inefficient type-I interferon signaling are risk factors for severe disease. PLoS Pathog. 2008;4(2):e29. doi: 10.1371/journal.ppat.0040029 18282093.
54. Stoermer Burrack KA, Hawman DW, Jupille HJ, Oko L, Minor M, Shives KD, et al. Attenuating mutations in nsP1 reveal tissue-specific mechanisms for control of Ross River virus infection. J Virol. 2014;88(7):3719–32. Epub 2014/01/17. doi: 10.1128/JVI.02609-13 24429363.
55. Her Z, Teng TS, Tan JJ, Teo TH, Kam YW, Lum FM, et al. Loss of TLR3 aggravates CHIKV replication and pathology due to an altered virus-specific neutralizing antibody response. EMBO Mol Med. 2014;7(1):24–41. doi: 10.15252/emmm.201404459 25452586.
56. Her Z, Malleret B, Chan M, Ong EK, Wong SC, Kwek DJ, et al. Active infection of human blood monocytes by Chikungunya virus triggers an innate immune response. J Immunol. 2010;184(10):5903–13. doi: 10.4049/jimmunol.0904181 20404274.
57. Ruiz Silva M, van der Ende-Metselaar H, Mulder HL, Smit JM, Rodenhuis-Zybert IA, Mechanism and role of MCP-1 upregulation upon chikungunya virus infection in human peripheral blood mononuclear cells. Sci Rep. 2016;6:32288. doi: 10.1038/srep32288 27558873.
58. Jupille HJ, Oko L, Stoermer KA, Heise MT, Mahalingam S, Gunn BM, et al. Mutations in nsP1 and PE2 are critical determinants of Ross River virus-induced musculoskeletal inflammatory disease in a mouse model. Virology. 2011;410(1):216–27. doi: 10.1016/j.virol.2010.11.012 21131014.
59. Hohl TM, Rivera A, Lipuma L, Gallegos A, Shi C, Mack M, et al. Inflammatory monocytes facilitate adaptive CD4 T cell responses during respiratory fungal infection. Cell Host Microbe. 2009;6(5):470–81.
60. Geissmann F, Jung S, Littman DR, Blood monocytes consist of two principal subsets with distinct migratory properties. Immunity. 2003;19(1):71–82. 12871640.
61. Xiong H, Carter RA, Leiner IM, Tang YW, Chen L, Kreiswirth BN, et al. Distinct Contributions of Neutrophils and CCR2+ Monocytes to Pulmonary Clearance of Different Klebsiella pneumoniae Strains. Infect Immun. 2015;83(9):3418–27. doi: 10.1128/IAI.00678-15 26056382.
62. Nascimento M, Huang SC, Smith A, Everts B, Lam W, Bassity E, et al. Ly6Chi monocyte recruitment is responsible for Th2 associated host-protective macrophage accumulation in liver inflammation due to schistosomiasis. PLoS Pathog. 2014;10(8):e1004282. doi: 10.1371/journal.ppat.1004282 25144366.
63. Samstein M, Schreiber HA, Leiner IM, Susac B, Glickman MS, Pamer EG, Essential yet limited role for CCR2(+) inflammatory monocytes during Mycobacterium tuberculosis-specific T cell priming. Elife. 2013;2:e01086.
64. Jupille HJ, Medina-Rivera M, Hawman DW, Oko L, Morrison TE, A tyrosine-to-histidine switch at position 18 of the Ross River virus E2 glycoprotein is a determinant of virus fitness in disparate hosts. J Virol. 2013;87(10):5970–84. doi: 10.1128/JVI.03326-12 23514884.
65. Muller U, Steinhoff U, Reis LF, Hemmi S, Pavlovic J, Zinkernagel RM, et al. Functional role of type I and type II interferons in antiviral defense. Science. 1994;264(5167):1918–21. 8009221.
66. Osada N, Kohara A, Yamaji T, Hirayama N, Kasai F, Sekizuka T, et al. The genome landscape of the african green monkey kidney-derived vero cell line. DNA Res. 2014;21(6):673–83. doi: 10.1093/dnares/dsu029 25267831.
67. Loo YM, Gale M, JrImmune signaling by RIG-I-like receptors. Immunity. 2011;34(5):680–92. doi: 10.1016/j.immuni.2011.05.003 21616437.
68. de Oliveira CA, Mantovani B, Latrunculin A is a potent inhibitor of phagocytosis by macrophages. Life Sci. 1988;43(22):1825–30. 3200109.
69. Frolov I, Hoffman TA, Pragai BM, Dryga SA, Huang HV, Schlesinger S, et al. Alphavirus-based expression vectors: strategies and applications. Proc Natl Acad Sci U S A. 1996;93(21):11371–7. 8876142.
70. Ivashkiv LB, Donlin LT, Regulation of type I interferon responses. Nat Rev Immunol. 2014;14(1):36–49. doi: 10.1038/nri3581 24362405.
71. Stoermer KA, Burrack A, Oko L, Montgomery SA, Borst LB, Gill RG, et al. Genetic ablation of arginase 1 in macrophages and neutrophils enhances clearance of an arthritogenic alphavirus. J Immunol. 2012;189(8):4047–59. doi: 10.4049/jimmunol.1201240 22972923.
72. Mora E, Guglielmotti A, Biondi G, Sassone-Corsi P, Bindarit: an anti-inflammatory small molecule that modulates the NFkappaB pathway. Cell Cycle. 2012;11(1):159–69. doi: 10.4161/cc.11.1.18559 22189654.
73. Terry RL, Getts DR, Deffrasnes C, van Vreden C, Campbell IL, King NJ, Inflammatory monocytes and the pathogenesis of viral encephalitis. J Neuroinflammation. 2012;9:270. doi: 10.1186/1742-2094-9-270 23244217.
74. Krejbich-Trotot P, Belarbi E, Ralambondrainy M, El-Kalamouni C, Viranaicken W, Roques P, et al. The growth of arthralgic Ross River virus is restricted in human monocytic cells. Virus Res. 2016;225:64–8. doi: 10.1016/j.virusres.2016.09.007 27637347.
75. Doherty Rl, Whitehead RH, Gorman BM, O’Gower AK, The isolation of a third group A arbovirus in Australia, with preliminary observations on its realtionships to epidemic polyarthritis. Aust J Sci. 1963;26:183–4.
76. Kuhn RJ, Niesters HG, Hong Z, Strauss JH, Infectious RNA transcripts from Ross River virus cDNA clones and the construction and characterization of defined chimeras with Sindbis virus. Virology. 1991;182(2):430–41. 1673812.
77. Dalgarno L, Rice CM, Strauss JH, Ross River virus 26 s RNA: complete nucleotide sequence and deduced sequence of the encoded structural proteins. Virology. 1983;129(1):170–87. 6310876.
78. Lindsay M, Oliveira N, Jasinska E, Johansen C, Harrington S, Wright AE, et al. An outbreak of Ross River virus disease in Southwestern Australia. Emerg Infect Dis. 1996;2(2):117–20.
79. Hawman DW, Stoermer KA, Montgomery SA, Pal P, Oko L, Diamond MS, et al. Chronic joint disease caused by persistent Chikungunya virus infection is controlled by the adaptive immune response. J Virol. 2013;87(24):13878–88. doi: 10.1128/JVI.02666-13 24131709.
80. Livak KJ, Schmittgen TD, Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 2001;25(4):402–8. doi: 10.1006/meth.2001.1262 11846609.